![Ronald W. Pero](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ronald W. Pero
Technik-/Wissenschafts-/F&E-Leiter bei RezGen5 Ltd.
Aktive Positionen von Ronald W. Pero
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
RezGen5 Ltd.
![]() RezGen5 Ltd. Pharmaceuticals: MajorHealth Technology RezGen5 Ltd. operates as a biopharmaceutical company, which focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with ageing, including metabolic diseases such as Type 2 Diabetes, Alzheimer's and cardiovascular diseases. The company was founded by Stuart Garret on June 15, 2012 and is headquartered in Hamilton, Bermuda. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
University of Lund | Corporate Officer/Principal | - | - |
Campamed, Inc. | Corporate Officer/Principal | - | - |
Deep South Partners LLC | Corporate Officer/Principal | - | - |
Karriereverlauf von Ronald W. Pero
Ehemalige bekannte Positionen von Ronald W. Pero
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
OPTIGENEX INC. | Corporate Officer/Principal | - | - |
ONCOTELIC THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Statistik
International
Vereinigte Staaten | 5 |
Schweden | 2 |
Bermuda | 2 |
Operativ
Corporate Officer/Principal | 5 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ONCOTELIC THERAPEUTICS, INC. | Health Technology |
OPTIGENEX INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
RezGen5 Ltd.
![]() RezGen5 Ltd. Pharmaceuticals: MajorHealth Technology RezGen5 Ltd. operates as a biopharmaceutical company, which focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with ageing, including metabolic diseases such as Type 2 Diabetes, Alzheimer's and cardiovascular diseases. The company was founded by Stuart Garret on June 15, 2012 and is headquartered in Hamilton, Bermuda. | Health Technology |
Campamed, Inc. | |
Deep South Partners LLC |
- Börse
- Insiders
- Ronald W. Pero
- Erfahrung